Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra D Pittman

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Tissue Engineering|March 22, 2006
Different osteogenic potentials of recombinant human BMP-6 adeno-associated virus and adenovirus in two rat strainsJin Zhong Li, Hongwei Li, Gerald R Hankins, et al.
Journal of Pharmaceutical Sciences|April 9, 2017
Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa<sup>I16L</sup>Chuenlei Parng, Victoria Markiewicz, Jianqing Chen, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086Chuenlei Parng, Pratap Singh, Debra D Pittman, et al.
Thrombosis and Haemostasis|June 12, 2024
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene ElaparvovecDebra D Pittman, Charles Carrieri, Holly Soares, et al.
Journal of Proteome Research|November 14, 2007
Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusionJiang Wu, Wei Liu, Eric Sousa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmasSunita Patel-Hett, Erika J Martin, Bassem M Mohammed, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritisChristopher J Edwards, Jeffrey L Feldman, Jonathan Beech, et al.
Osteoarthritis and Cartilage|July 21, 2004
Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture systemMaya Arai, Dina Anderson, Yahya Kurdi, et al.
Blood|October 17, 2020
Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkersDebra D Pittman, Patrick C Hines, David Beidler, et al.
Critical Care (London, England)|November 29, 2007
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infectionEmily C Lutterloh, Steven M Opal, Debra D Pittman, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Tissue Engineering|March 22, 2006
Different osteogenic potentials of recombinant human BMP-6 adeno-associated virus and adenovirus in two rat strainsJin Zhong Li, Hongwei Li, Gerald R Hankins, et al.
Journal of Pharmaceutical Sciences|April 9, 2017
Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa<sup>I16L</sup>Chuenlei Parng, Victoria Markiewicz, Jianqing Chen, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086Chuenlei Parng, Pratap Singh, Debra D Pittman, et al.
Thrombosis and Haemostasis|June 12, 2024
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene ElaparvovecDebra D Pittman, Charles Carrieri, Holly Soares, et al.
Journal of Proteome Research|November 14, 2007
Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusionJiang Wu, Wei Liu, Eric Sousa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmasSunita Patel-Hett, Erika J Martin, Bassem M Mohammed, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritisChristopher J Edwards, Jeffrey L Feldman, Jonathan Beech, et al.
Osteoarthritis and Cartilage|July 21, 2004
Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture systemMaya Arai, Dina Anderson, Yahya Kurdi, et al.
Blood|October 17, 2020
Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkersDebra D Pittman, Patrick C Hines, David Beidler, et al.
Critical Care (London, England)|November 29, 2007
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infectionEmily C Lutterloh, Steven M Opal, Debra D Pittman, et al.
Pageof 4